STAT July 23, 2024
Allison DeAngelis

When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention.

Singh had been a mainstay in the immunology and oncology fields, helping to invent the blockbuster drug Skyrizi and several other treatments during stints at Johnson & Johnson and Boehringer Ingelheim. “If Sanjaya Singh is doing...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Coalition encourages employers to offer obesity coverage
Bringing Systems Thinking To Drug Value Assessment
How Can Startups Navigate the Difficult Funding Environment
As medication prices rise, hospitals turn to drugmakers

Share This Article